@article{5489b07d0d5045c88c2c59ebe94915cb,
title = "Advances and Future Directions in Molecular Breast Imaging",
abstract = "Molecular breast imaging (MBI) using99mTc-sestamibi has advanced rapidly over the past decade. Technical advances allow lower-dose, higher-resolution imaging and biopsy capability. MBI can be used for supplemental breast cancer screening with mammography for women with dense breasts, as well as to assess neoadjuvant therapy response, evaluate disease extent, and predict breast cancer risk. This article highlights the current state of the art and future directions in MBI. COPYRIGHT ",
keywords = "MBI, breast specific g-imaging, molecular breast imaging, nuclear breast imaging, sestamibi",
author = "Covington, {Matthew F.} and Parent, {Ephraim E.} and Dibble, {Elizabeth H.} and Rauch, {Gaiane M.} and Fowler, {Amy M.}",
note = "Funding Information: Matthew Covington is a consultant for Invicro, LLC, for medical imaging review. Ephraim Parent receives research funding from Blue Earth Diagnostics. Gaiane Rauch receives research funding from GE Healthcare. Amy Fowler receives research support from GE Healthcare and book chapter royalties from Elsevier, Inc. All disclosures are outside the scope of this project. No other potential conflict of interest relevant to this article was reported. Publisher Copyright: {\textcopyright} 2022 by the Society of Nuclear Medicine and Molecular Imaging.",
year = "2022",
month = jan,
day = "1",
doi = "10.2967/jnumed.121.261988",
language = "English (US)",
volume = "63",
pages = "17--21",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "1",
}